Sequential Treatment with FLAG-IDA Followed by Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapse/Refractory or Adverse-Risk Leukemia

Patients with relapse/refractory or adverse-risk leukemia have dismal prognosis with current therapeutic approaches. Salvage chemotherapy followed by allogeneic hematopoietic stem-cell transplantation (HSCT) is advisable but not always attainable due to disease resistance and the toxicity associated with current salvage approaches.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Source Type: research